ASSET | DATE | % RETURN |
---|---|---|
Sangamo Therapeutics (SGMO) | 6/1/2000 - 9/30/2000 | 463.64% |
Extreme Networks (EXTR) | 6/1/2000 - 9/30/2000 | 356.86% |
FuelCell Energy (FCEL) | 6/1/2000 - 9/30/2000 | 339.93% |
XOMA (XOMA) | 6/1/2000 - 9/30/2000 | 323.85% |
Amtech Systems (ASYS) | 6/1/2000 - 9/30/2000 | 322.9% |
Pixelworks (PXLW) | 6/1/2000 - 9/30/2000 | 295.34% |
Manhattan Associates (MANH) | 6/1/2000 - 9/30/2000 | 228.86% |
Nortech Systems (NSYS) | 6/1/2000 - 9/30/2000 | 212.5% |
Lexicon Pharmaceuticals (LXRX) | 6/1/2000 - 9/30/2000 | 212.35% |
Biogen (BIIB) | 6/1/2000 - 9/30/2000 | 165.7% |
Bel Fuse A (BELFA) | 6/1/2000 - 9/30/2000 | 147.52% |
Microbot Medical (MBOT) | 6/1/2000 - 9/30/2000 | 146.16% |
Caesars Entertainment (CZR) | 6/1/2000 - 9/30/2000 | 136.36% |
Champions Oncology (CSBR) | 6/1/2000 - 9/30/2000 | 134.38% |
Veeco Instruments (VECO) | 6/1/2000 - 9/30/2000 | 134.19% |
SurModics (SRDX) | 6/1/2000 - 9/30/2000 | 131.13% |
Celldex Therapeutics (CLDX) | 6/1/2000 - 9/30/2000 | 127.63% |
Cirrus Logic (CRUS) | 6/1/2000 - 9/30/2000 | 127.11% |
Vertex Pharmaceuticals (VRTX) | 6/1/2000 - 9/30/2000 | 126.85% |
Perdoceo Education (PRDO) | 6/1/2000 - 9/30/2000 | 122.85% |
Acacia Research (ACTG) | 6/1/2000 - 9/30/2000 | 119.69% |
Amedisys (AMED) | 6/1/2000 - 9/30/2000 | 119.36% |
Myriad Genetics (MYGN) | 6/1/2000 - 9/30/2000 | 119.28% |
Bruker (BRKR) | 6/1/2000 - 9/30/2000 | 116.79% |
Bel Fuse B (BELFB) | 6/1/2000 - 9/30/2000 | 114.3% |